Katherine Parks
Family · Rochester, NYNPI 1629236302
Payments from drug & device makers
Across 121 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$550
- Novartis$316
- Johnson & Johnson$280
- Lilly USA, LLC$180
- Sun Pharmaceutical Industries Inc.$173
- Sanofi$136
- plus $866 from 18 others
What the payments were for
- Food & beverage$2,41597%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $550 |
| Novartis | 12 | $316 |
| Johnson & Johnson | 11 | $280 |
| Lilly USA, LLC | 8 | $180 |
| Sun Pharmaceutical Industries Inc. | 9 | $173 |
| Sanofi | 6 | $136 |
| Amgen | 5 | $111 |
| UCB, Inc. | 5 | $102 |
| Galderma Laboratories, L.p. | 5 | $91 |
| Pfizer | 5 | $84 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Arcutis Biotherapeutics, Inc. | 4 | $62 |
| Mayne Pharma Commercial LLC | 7 | $47 |
| Incyte Corporation | 2 | $47 |
| VYNE Pharmaceuticals Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Boehringer Ingelheim | 1 | $29 |
| Organon | 3 | $24 |
| Surgenex LLC | 1 | $24 |
| Almirall LLC | 1 | $23 |
| Journey Medical Corporation | 1 | $22 |
| Revance Therapeutics, Inc. | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| LEO Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$120
How this compares
$2,500 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 33 | $2,435 |
| Tacrolimus | 14 | $1,937 |
| Betamethasone Dipropionate | 35 | $1,233 |
| Metronidazole | 24 | $1,042 |
| Clindamycin Phosphate | 18 | $897 |
| Ketoconazole | 68 | $846 |
| Triamcinolone Acetonide | 58 | $615 |
| Fluocinolone Acetonide Oil | 11 | $587 |
| Mometasone Furoate | 23 | $538 |
| Hydrocortisone | 50 | $229 |
| Mupirocin | 28 | $158 |
Paid to pharmacies, not to this prescriber.
Other family in Rochester
- Stephanie BartlettRochester$63K
- Orlando HarrisRochester$30K
- Laron NelsonRochester$28K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.